Singapore markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
143.41+1.02 (+0.72%)
At close: 04:00PM EST
143.25 -0.16 (-0.11%)
After hours: 07:51PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
55,138,000
58,054,000
56,197,000
45,804,000
33,266,000
Cost of revenue
18,881,000
17,414,000
17,446,000
15,387,000
7,439,000
Gross profit
36,257,000
40,640,000
38,751,000
30,417,000
25,827,000
Operating expenses
Research development
7,538,000
6,510,000
7,084,000
6,557,000
6,407,000
Selling general and administrative
13,096,000
15,260,000
12,349,000
11,299,000
6,942,000
Total operating expenses
20,454,000
21,826,000
19,865,000
17,856,000
12,459,000
Operating income or loss
15,803,000
18,814,000
18,886,000
12,561,000
13,368,000
Interest expense
1,872,000
2,230,000
2,384,000
2,280,000
1,509,000
Total other income/expenses net
-6,018,000
-3,293,000
-3,513,000
-6,883,000
-3,433,000
Income before tax
8,003,000
13,477,000
12,989,000
3,398,000
8,426,000
Income tax expense
1,482,000
1,632,000
1,440,000
-1,224,000
544,000
Income from continuing operations
6,521,000
11,845,000
11,549,000
4,622,000
7,882,000
Net income
6,514,000
11,836,000
11,542,000
4,616,000
7,882,000
Net income available to common shareholders
6,503,000
11,836,000
11,542,000
4,616,000
7,882,000
Basic EPS
3.66
6.65
6.48
2.73
5.30
Diluted EPS
3.65
6.63
6.45
2.72
5.28
Basic average shares
1,768,750
1,771,000
1,770,000
1,667,000
1,481,000
Diluted average shares
1,774,250
1,778,000
1,777,000
1,673,000
1,484,000